Lauren Biscaldi is the Managing Editor of Drug Topics.
Conference Recap, Part 1: NACDS Total Store Expo
Did you miss this year’s NACDS Total Store Expo? Check out the first part of our Conference Recap.
Food Is Medicine: Pharmacists Can Advance Policies for Healthier Communities
It's an exciting time for policies being made around food as medicine.
Pharmacists Are On the Front Line of Women’s Health and Wellness
Only 4% of money for research and development is used to focus on women’s health issues.
Expert Interview: Exploring the Full Capabilities of Generative AI
Generative AI is the fastest growing technology ever, and is anticipated to be adopted faster than the world wide web.
Illinois Governor Signs Legislation Targeting PBM Retaliation
Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.
Video: 2023 Pharmacy Trends Forecast
Catch up on the latest pharmacy issues and trends with Doug Long, vice president of industry relations at IQVIA.
Video: Bringing Health Care Closer to Home
What can pharmacists do to bring innovative care models into their stores to serve their communities?
Welcome to San Diego: Things to Do at NACDS Total Store Expo
After sessions end, head out to explore the city of San Diego.
Conference Preview: NACDS Total Store Expo
The NACDS Total Store Expo takes place August 12 through 14, 2023 in San Diego, California.
Zuranolone Approved as First, Only Oral Medication to Treat Postpartum Depression
Approximately 1 in 8 women in the United States experience postpartum depression.
Pfizer's New Migraine Treatment Now Available in US Pharmacies: What You Need to Know
Zavegepant (Zavzpret) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA for acute migraine treatment in adults.
Senate Introduces Bipartisan Bill to Ensure Continued Access to Pharmacist Care, Services for Seniors
The Equitable Community Access to Pharmacy Services legislation was introduced earlier this year in the House of Representatives.
Professional CGM Use May Improve HbA1c in Type 2 Diabetes
FTC Issues Statement Withdrawing Previous Support of PBM Advocacy
Pharmacy Organizations Request Delay, Stepwise Implementation of DSCSA Provisions
NCPA, NACDS, and APhA have joined the Healthcare Distribution Alliance in calling for a delay in the implementation of DSCSA.
COVID-19: After the Emergency Ends
The COVID-19 public health emergency is over. What happens now?
Corticosteroid Therapy Does Not Impact Overall, Progression Free Survival in ICI Therapy
Moderna Announces Submission of BLA, Global Marketing Authorizations for RSV Vaccine
Five Adalimumab Biosimilars Now Available in US Market
These medications join adalimumab-atto, which launched on January 31.
CGM Use Decreases Hypoglycemic Episodes in Underserved Patients With T2D
Advocating for Technology Can Improve Rates of CGM Use, Clinical Outcomes
Continuous glucose monitor and insulin pump use improved HbA1c.
McKesson Is Ready to Help Customers Navigate DSCSA
The company has been working since 2015 to implement the track and trace elements required by the Drug Supply Chain Security Act.
Perpetual Inventory Management Creates Cash Flow Advantage for Pharmacy Owners
One Nebraska community pharmacy owner was able to save $20,000 in inventory costs.
Breaking: CDC ACIP Recommends RSV Vaccination for Older Adults
The first RSV vaccines were approved by the FDA earlier this year.
FDA Committee Recommends Development of Monovalent, XBB-Containing Vaccines
The VRBPAC committee voted 21-0 in favor of this recommendation.
CGM Use May Lead to Behavioral Modifications in Adolescent T2D
Pharmacists Role in Opioid Stewardship, Perioperative Main Management Crucial
Prescribing Alert Increases Rates of Naloxone, Opioid Co-Prescriptions
The alert was implemented after passage of a state senate bill.
CGRP Inhibitors Significantly Reduce Disability in Migraine
Study results add to the body of evidence demonstrating the efficacy of CGRP inhibitors for migraine treatment and prophylaxis.
Novel ADHD Therapy More Tolerable, Less Effective Than Current Treatment Options
Centanafadine is a serotonin-norepinephrine-dopamine triple reuptake inhibitor.
2 Clarke Drive Cranbury, NJ 08512